"The US Food and Drug Administration (FDA) today approved asfotase alfa (Strensiq, Alexion Pharmaceuticals) as the first-ever therapy for patients who develop hypophosphatasia, a rare metabolic bone disorder, in childhood.
Patients Should Be Advised That:
- PANCRECARB® (pancrelipase) should not be crushed or chewed.
- PANCRECARB® (pancrelipase) capsules should be swallowed with liquids at the start of a meal.
- PANCRECARB® (pancrelipase) , when removed from the gelatin capsule, should be swallowed immediately and not retained in the mouth.
- Liquids should be consumed liberally while dosing with PANCRECARB® (pancrelipase)
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Pancrecarb Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.